Efficient generation of antibodies to oncoproteins by using synthetic peptide antigens.
about
Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodiesImpact of immunization technology and assay application on antibody performance--a systematic comparative evaluationAnti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.Monoclonal antibody targeting complement C9 binding domain of Trichinella spiralis paramyosin impairs the viability of Trichinella infective larvae in the presence of complement.Cloning and characterization of a Chlamydia trachomatis L3 DNA fragment that codes for an antigenic region of the major outer membrane protein and specifically hybridizes to the C- and C-related-complex serovars.Antigenic determinants in proteins coincide with surface regions accessible to large probes (antibody domains).Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes.Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cellsEngineered human vaccines.Ras is not required for the interleukin 3-induced proliferation of a mouse pro-B cell line, BaF3.Hedgehog and its patched-smoothened receptor complex: a novel signalling mechanism at the cell surface.Acyl-CoA-binding protein from cow. Binding characteristics and cellular and tissue distribution.Peptides as antigens. Importance of orientation.Expression of Ha-ras oncogene p21 protein in relation to the cell cycle of cultured human tumor cells.Acyl-CoA-binding protein in the rat. Purification, binding characteristics, tissue concentrations and amino acid sequence.
P2860
Q24563990-4556EF8E-ECB2-4862-91BF-63DA788F889DQ28741074-D8137C5E-2C01-4740-88BD-D1878FD02395Q33610591-C6A91BE0-C1BA-4816-9271-E68A62436C20Q33913389-9D20396F-4E08-430A-98C6-B16032D536B3Q35090581-E3DAD911-B91D-4C67-A490-69995B8BEE54Q35585238-AF1F1A85-7F5D-4D33-A58F-68EBE3B8EF4CQ36220190-4E78C973-B393-4CCC-AFFF-E9BAB308BC32Q36896486-94CE71B5-BE48-42E3-8403-4CCC7F4F5101Q40754536-9B6B6485-A900-4589-9B68-3B7E46D81DBBQ41270140-2EEEC1D4-7426-43F8-A827-A680CACCB549Q41581685-37EDB947-E081-4E29-8145-8EC9E959A1D9Q41965102-3FC54610-1DB1-42D4-929F-50BA792B83D7Q42026698-5F8034CE-9690-4F8F-98D3-B9DCBB0E3616Q42738289-7B8FCA78-EA11-428F-865C-8FAF5A63837CQ42802718-656E3D15-CAEE-475D-80B7-50B382921B5C
P2860
Efficient generation of antibodies to oncoproteins by using synthetic peptide antigens.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1985
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficient generation of antibodies to oncoproteins by using synthetic peptide antigens.
@en
Efficient generation of antibodies to oncoproteins by using synthetic peptide antigens.
@nl
type
label
Efficient generation of antibodies to oncoproteins by using synthetic peptide antigens.
@en
Efficient generation of antibodies to oncoproteins by using synthetic peptide antigens.
@nl
prefLabel
Efficient generation of antibodies to oncoproteins by using synthetic peptide antigens.
@en
Efficient generation of antibodies to oncoproteins by using synthetic peptide antigens.
@nl
P2093
P2860
P356
P1476
Efficient generation of antibodies to oncoproteins by using synthetic peptide antigens.
@en
P2093
P2860
P304
P356
10.1073/PNAS.82.10.3400
P407
P577
1985-05-01T00:00:00Z